- Home
- WVE vs FLNC Comparison
WVE vs FLNC Comparison
Compare WVE & FLNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WVE
- FLNC
- Stock Information
- Founded
- WVE 2012
- FLNC 2018
- Country
- WVE Singapore
- FLNC United States
- Employees
- WVE N/A
- FLNC N/A
- Industry
- WVE Biotechnology: Pharmaceutical Preparations
- FLNC Industrial Machinery/Components
- Sector
- WVE Health Care
- FLNC Miscellaneous
- Exchange
- WVE Nasdaq
- FLNC Nasdaq
- Market Cap
- WVE 915.6M
- FLNC 802.6M
- IPO Year
- WVE 2015
- FLNC 2021
- Fundamental
- Price
- WVE $8.40
- FLNC $9.38
- Analyst Decision
- WVE Strong Buy
- FLNC Hold
- Analyst Count
- WVE 14
- FLNC 18
- Target Price
- WVE $19.86
- FLNC $8.38
- AVG Volume (30 Days)
- WVE 1.6M
- FLNC 5.6M
- Earning Date
- WVE 07-30-2025
- FLNC 08-06-2025
- Dividend Yield
- WVE N/A
- FLNC N/A
- EPS Growth
- WVE N/A
- FLNC N/A
- EPS
- WVE N/A
- FLNC N/A
- Revenue
- WVE $104,939,000.00
- FLNC $2,329,871,000.00
- Revenue This Year
- WVE N/A
- FLNC $2.61
- Revenue Next Year
- WVE $4.90
- FLNC $27.01
- P/E Ratio
- WVE N/A
- FLNC N/A
- Revenue Growth
- WVE N/A
- FLNC 6.08
- 52 Week Low
- WVE $5.04
- FLNC $3.46
- 52 Week High
- WVE $16.74
- FLNC $24.00
- Technical
- Relative Strength Index (RSI)
- WVE 63.68
- FLNC 66.85
- Support Level
- WVE $7.69
- FLNC $8.16
- Resistance Level
- WVE $8.70
- FLNC $10.35
- Average True Range (ATR)
- WVE 0.53
- FLNC 0.54
- MACD
- WVE 0.07
- FLNC 0.03
- Stochastic Oscillator
- WVE 82.63
- FLNC 64.19
About WVE Wave Life Sciences Ltd.
WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.
About FLNC Fluence Energy Inc.
Fluence Energy Inc is enabling the global clean energy transition with market-leading energy storage products and services, and digital applications for renewables and storage. Geographically, it derives a majority of its revenue from the Americas.